HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eijun Itakura Selected Research

Eijun Itakura Research Topics

Disease

8Melanoma (Melanoma, Malignant)
12/2020 - 10/2004
7Neoplasms (Cancer)
06/2019 - 02/2002
3Neoplasm Metastasis (Metastasis)
01/2015 - 06/2011
2Lymphatic Metastasis
01/2008 - 09/2006
1Drug-Related Side Effects and Adverse Reactions
08/2020
1Lymphangioma (Cavernous Lymphangioma)
03/2009
1Cystic Lymphangioma (Hygroma)
03/2009
1Nevus (Nevi)
03/2008
1Hemangiosarcoma (Angiosarcoma)
01/2008
1Lymphedema (Milroy Disease)
01/2008
1Rhabdoid Tumor (Rhabdoid Tumors)
02/2002

Drug/Important Bio-Agent (IBA)

3IpilimumabIBA
12/2020 - 11/2019
3Messenger RNA (mRNA)IBA
11/2011 - 03/2008
2NivolumabIBA
12/2020 - 11/2019
2Immune Checkpoint InhibitorsIBA
08/2020 - 06/2019
2CytokinesIBA
01/2015 - 06/2011
2Formaldehyde (Formol)FDA Link
11/2011 - 03/2008
2ParaffinIBA
11/2011 - 03/2008
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
11/2011 - 06/2011
2Vascular Endothelial Growth Factor CIBA
03/2009 - 01/2008
1CTLA-4 AntigenIBA
08/2020
1Monoclonal AntibodiesIBA
08/2020
1Proteins (Proteins, Gene)FDA Link
11/2011
1Hematoxylin (Haematoxylon)IBA
11/2011
1Eosine Yellowish-(YS) (Eosin)IBA
11/2011
1RNA (Ribonucleic Acid)IBA
11/2011
1Interleukin-10 (Interleukin 10)IBA
06/2011
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
03/2009
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2009
1dopachrome isomeraseIBA
03/2008
1EpitopesIBA
03/2008
1MART-1 AntigenIBA
03/2008
1Vascular Endothelial Growth FactorsIBA
01/2008
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
01/2008
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2008
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
09/2006
1Keratins (Keratin)IBA
02/2002
1Keratin-8 (Keratin 8)IBA
02/2002
1Indicators and Reagents (Reagents)IBA
02/2002
1VimentinIBA
02/2002

Therapy/Procedure

2Therapeutics
12/2020 - 09/2006
1Lymph Node Excision (Lymph Node Dissection)
10/2004